Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00636987 · ClinicalTrials.gov registry record · NA

Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra

A NA study, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
297
Enrollment target

NCT00636987 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 297 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00636987, a NA study, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
297 participants
Enrollment target

Study Summary

The purpose of this study is to further evaluate the long-term safety and effectiveness of the Biocor and Biocor Supra Valves.

Interventions

  • DEVICE Biocor and Biocor Supra valves

Trial Details

FieldValue
Enrollment Target 297 participants
Start Date 2007-04
Est. Completion 2016-03
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT00636987

The ClinicalTrials.gov registry entry for NCT00636987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 297 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Biocor and Biocor Supra valves is the first listed.

NCT00636987 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00636987 about?

NCT00636987 is a clinical study titled "Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra". The purpose of this study is to further evaluate the long-term safety and effectiveness of the Biocor and Biocor Supra Valves.

What is the current status of trial NCT00636987?

This trial is currently completed. It is a NA study. The enrollment target is 297 participants. The study started on 2007-04. Estimated completion is 2016-03.

What interventions are being tested in trial NCT00636987?

The interventions under investigation include: Biocor and Biocor Supra valves (DEVICE).

Who is sponsoring clinical trial NCT00636987?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.